APYX vs WST · rev $48.1M vs P/E 35, rev $2.89B
Apyx Medical Inc (APYX) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported WST revenue for 2024-12-31 was $2.89B. Net income was $492.7M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. WST currently screens at market cap $15.97B and trailing P/E 34.8.
APYX currently screens at market cap $179.6M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the APYX and WST stock pages for the full models.
Not investment advice.